Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,893 | -11,227 | -5,966 | -21,092 | -13,701 |
| Depreciation Amortization | 434 | 287 | 146 | 1,248 | 1,102 |
| Accounts receivable | -983 | -599 | -579 | N/A | -475 |
| Accounts payable and accrued liabilities | -2,470 | -1,312 | -945 | N/A | 1,178 |
| Other Working Capital | -3,462 | -2,443 | -2,100 | -2,231 | -2,450 |
| Other Operating Activity | 4,035 | 2,312 | 1,667 | 2,151 | 186 |
| Operating Cash Flow | $-18,339 | $-12,982 | $-7,777 | $-19,924 | $-14,160 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -164 | -89 | -48 | -58 | -42 |
| Purchase Sale Intangibles | -2,500 | -500 | -500 | N/A | 0 |
| Other Investing Activity | -2,500 | -500 | -500 | -1,500 | 0 |
| Investing Cash Flow | $-2,664 | $-589 | $-548 | $-1,558 | $-42 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,912 |
| Debt Issued | N/A | N/A | N/A | N/A | 8,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -5,000 |
| Common Stock Issued | 12 | 8 | 3 | N/A | 6 |
| Other Financing Activity | 14,415 | 12,158 | 481 | 27,414 | -3,149 |
| Financing Cash Flow | $14,427 | $12,166 | $484 | $27,414 | $4,769 |
| Exchange Rate Effect | -1 | 0 | -5 | 0 | N/A |
| Beginning Cash Position | 17,278 | 17,278 | 17,278 | 11,346 | 11,346 |
| End Cash Position | 10,701 | 15,873 | 9,432 | 17,278 | 1,913 |
| Net Cash Flow | $-6,577 | $-1,405 | $-7,846 | $5,932 | $-9,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,339 | -12,982 | -7,777 | -19,924 | -14,160 |
| Capital Expenditure | -164 | -89 | -48 | N/A | -42 |
| Free Cash Flow | -18,503 | -13,071 | -7,825 | -19,924 | -14,202 |